Boston Scientific Corp's Fiscal Year is From January To December - All Figures are in USD, Millions.
The item "Total-Other-Finance-Cost" stands at 264.00 Million United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2023.
Boston Scientific Corp's third quarter result of 99.00 Million USD for the item "Total Other Finance Cost" represents an increase of 10.00 percent compared to it's second quarter result.
Also, Boston Scientific Corp's third quarter result of 99.00 Million USD for the item "Total Other Finance Cost" represents an increase of 25.32 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Boston Scientific Corp's third quarter result of 264.00 Million USD for the item "Total Other Finance Cost" represents an increase of 8.20 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 216.00 Million United States Dollars compared to the value the year prior.
The 1 year change is 216.00 Million United States Dollars.
The 3 year change is 128.00 Million United States Dollars.
The 5 year change is 143.00 Million United States Dollars.
The 10 year change is 542.00 Million United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Total Other Finance Cost | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Total Other Finance Cost | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Total Other Finance Cost | 172,241,486,586.05 |
![]() | Danaher Corporation - Total Other Finance Cost | 162,006,663,168.00 |
![]() | Stryker Corporation - Total Other Finance Cost | 139,209,850,880.00 |